The Institute for Stem Cell and Regenerative Medicine (ISCRM) is committed to the ethical pursuit of basic research to unleash the enormous potential of stem cells and thereby develop therapies that improve patient health worldwide.
The Institute, founded in March 2006, consists of a world-class team of over
130 faculty conducting basic research on stem and progenitor cells. The
Institute is linked by the shared commitment of the faculty to leverage this
research to develop improved therapies, and cures, for patients.
Read more >>
ISCRM's Director Named AAAS Fellow
Congratulations to Dr. Randall Moon, ISCRM's Director for being elected a Fellow in the American Academy of the Arts and Sciences. Read more >>
2013 ISCRM Research Award Winners Announced
The Institute for Stem Cell and Regenerative Medicine is pleased to announce the 2013 winners of the Tietze Research Awards, funded through a generous multi-year commitment by the John H. Tietze Foundation.
The John H. Tietze Stem Cell Scientist Awards go to:
David L. Mack, PhD, Assistant Professor, Rehabilitation Medicine and Eirini Papapetrou, MD, PhD, Assistant Professor, Medicine/Hematology
The Jaconette L. Tietze Young Scientist Award goes to: Jason Berndt, PhD, Acting Instructor, Pharmacology (Moon Lab)
For more information, click here >>
In The News
Engineered biomaterial could improve success of medical implants
Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body’s natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response. Their findings were published online this week in the journal Nature Biotechnology.
The UW researchers, led by Dr. Buddy Ratner, professor of bioengineering and of chemical engineering, created a synthetic substance that fully resists the body’s natural attack response to foreign objects. Medical devices such as artificial heart valves, prostheses and breast implants could be coated with this polymer to prevent the body from rejecting an implanted object. Read more >>
Unlocking the potential of Wnt signals in regenerative medicine
Randall Moon, director of the UW’s Institute for Stem Cell & Regenerative Medicine (ISCRM) and professor of pharmacology, and Jason Berndt, acting instructor of pharmacology, wrote a review in the March 22 edition of Science about the promise of manipulating Wnt pathways for disease treatment.
The Wnt signaling pathway is a network of proteins that passes signals from receptors on the surface of the cell to the cell's nucleus. It controls cell-to-cell communication in cell proliferation and differentiation during development and healing. Read more >>
Horner Lab/Moon Lab
Tuesday, May 28, 3:30-4:30PM
Brotman Auditorium, 850 Republican Street
Xi He, PhD
Professor, Harvard Medical School
"Understanding Wnt signaling and Wnt morphogen regulation"
Friday, June 7, 11:00AM-12:00PM
Orin Smith Auditorium, 850 Republican Street
For more information >>
Recent Event Highlight
Konrad Hochedlinger, PhD, gives a talk to ISCRM community
Dr. Hochedlinger, Professor in the Department of Stem Cell and Regenerative Biology at Harvard University gave a talk on Tuesday, May 7th about "Understanding cellular reprogramming and pluripotency" to the ISCRM community. To view a recording of his presentation, click here >>